HER2 Negative Breast Cancer Overview

Save information for later
Sign Up

Learn About HER2 Negative Breast Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top HER2 Negative Breast Cancer Local Doctors?
Kevin M. Kalinsky
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
Languages Spoken:
English
Offers Telehealth

Kevin Kalinsky is an Oncologist in Atlanta, Georgia. Dr. Kalinsky is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Christoph Thomssen
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer
Ernst Grube Str. 40, 
Halle, NI, DE 

Christoph Thomssen practices in Halle, Germany. Mr. Thomssen is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are HER2 Negative Breast Cancer, Breast Cancer, BRCA Positive Breast Cancer, Mastectomy, and Hormone Replacement Therapy (HRT).

 
 
 
 
Learn about our expert tiers
Learn More
Patrick Neven
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

UZ Leuven, Campus Gasthuisberg

Leuven, VLG, BE 

Patrick Neven practices in Leuven, Belgium. Mr. Neven is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Menopause, Mastectomy, and Oophorectomy.

What are the latest HER2 Negative Breast Cancer Clinical Trials?
A Phase I Study of Concurrent Abemaciclib and Radiation Therapy (RT) for Patients With Metastatic Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Breast Cancer

Summary: The purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Summary: This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.